L. Cals

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet · 2019 · 125 citations

Breast Oncology, Oncology, Early Breast Cancer +6

Discordances in Estrogen Receptor Status, Progesterone Receptor Status, and HER2 Status Between Primary Breast Cancer and Metastasis

Elsa Curtit, Virginie Nerich, Laura Mansi et al. · The Oncologist · 2013 · 92 citations · Full text

Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck

Xavier Pivot, Éric Raymond, Brigitte Laguerre et al. · British Journal of Cancer · 2001 · 88 citations · Full text

Cetuximab+FOLFIRI as first-line treatment for metastatic colorectal CA

P. Rougier, Jean‐Luc Raoul, Jean‐Luc Van Laethem et al. · Journal of Clinical Oncology · 2004 · 88 citations

Folfiri Regimen, Cancer Therapeutics, Gastrointestinal Oncology +15

Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study

Jean‐Luc Raoul, Jean‐Luc Van Laethem, Marc Peeters et al. · BMC Cancer · 2009 · 43 citations · Full text